Inventor · disambiguated record
Bruce D. Dorsey
Also filed as: DORSEY BRUCE · DORSEY BRUCE D
54 granted patents·18 pending applications·630 citations·filing 1993–2024
98Inventor score
Top patents by PatentIndex Score
72 records- 0198US5413999AHIV protease inhibitors useful for the treatment of AIDSMERCK & CO INC·Filed 1993·Granted May 9, 1995·247 cites·13 claims
- 0295US11702388B21,4-substituted piperidine derivatives89BIO LTD·Filed 2020·Granted Jul 18, 2023·3 cites·20 claims
- 0393US10851057B21,4-substituted piperidine derivatives89BIO LTD·Filed 2019·Granted Dec 1, 2020·5 cites·16 claims
- 0493US5866573APyrazinone thrombin inhibitorsMERCK & CO INC·Filed 1997·Granted Feb 2, 1999·69 cites·18 claims
- 0592US7601716B2Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitorsCEPHALON INC·Filed 2007·Granted Oct 13, 2009·23 cites·19 claims
- 0690US10221135B21,4-substituted piperidine derivatives89BIO LTD·Filed 2018·Granted Mar 5, 2019·7 cites·30 claims
- 0790US9902696B21,4-substituted piperidine derivativesCEPHALON INC·Filed 2016·Granted Feb 27, 2018·7 cites·21 claims
- 0889US8148391B2Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitorsAHMED GULZAR·Filed 2007·Granted Apr 3, 2012·17 cites·8 claims
- 0988US10919875B2Substituted 4-benzyl and 4-benzoyl piperidine derivatives89BIO LTD·Filed 2016·Granted Feb 16, 2021·4 cites·26 claims
- 1087US9604994B2Thienopyrimidine inhibitors of atypical protein kinase CCANCER RES TECH LTD·Filed 2014·Granted Mar 28, 2017·12 cites·26 claims
- 1187US7919502B2Pyridopyrazines and derivatives thereof as ALK and c-MET inhibitorsCEPHALON INC·Filed 2009·Granted Apr 5, 2011·9 cites·8 claims
- 1287US2025257035A11,4-Substituted Piperidine DerivativesCEPHALON LLC·Filed 2024·Application pending·0 cites
- 1386US12098130B21,4-substituted piperidine derivatives89BIO LTD·Filed 2023·Granted Sep 24, 2024·0 cites·18 claims
- 1485US8552186B2Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitorsAHMED GULZAR·Filed 2012·Granted Oct 8, 2013·10 cites·26 claims
- 1582US10358447B2Substituted 2-N-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using sameARBUTUS BIOPHARMA CORP·Filed 2018·Granted Jul 23, 2019·3 cites·24 claims
- 1682US9914730B2Azaquinazoline inhibitors of Atypical protein Kinase CIGNYTA INC·Filed 2013·Granted Mar 13, 2018·6 cites·13 claims
- 1782US9896446B2Azaquinazoline inhibitors of atypical protein kinase CIGNYTA INC·Filed 2015·Granted Feb 20, 2018·4 cites·14 claims
- 1882US5668289APyridinone thrombin inhibitorsMERCK & CO INC·Filed 1996·Granted Sep 16, 1997·60 cites·17 claims
- 1981US12083118B2Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2019·Granted Sep 10, 2024·2 cites·26 claims
- 2081US8080561B2Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitorsDORSEY BRUCE D·Filed 2011·Granted Dec 20, 2011·8 cites·13 claims
- 2180US12441702B2Substituted 4-benzyl and 4-benzoyl piperidine derivatesCEPHALON LLC·Filed 2023·Granted Oct 14, 2025·0 cites·6 claims
- 2279US5733907AProdrugs of an inhibitor of HIV proteaseMERCK & CO INC·Filed 1996·Granted Mar 31, 1998·24 cites·5 claims
- 2377US10028956B2Methods of treating various cancers using an AXL/cMET inhibitor in combination with other agentsIGNYTA INC·Filed 2014·Granted Jul 24, 2018·2 cites·8 claims
- 2474US9487529B2Macrocyclic compounds as ALK, FAK and JAK2 inhibitorsCEPHALON INC·Filed 2013·Granted Nov 8, 2016·1 cites·22 claims
- 2574US7504401B2Anti-cancer agents and uses thereofLOCUS PHARMACEUTICALS INC·Filed 2004·Granted Mar 17, 2009·6 cites·60 claims
- 2674US2024374595A1Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 2773US10550084B2Substituted 1-hydroxy-pyridin-2(1H)-ones, and methods of making and using sameARBUTUS BIOPHARMA CORP·Filed 2018·Granted Feb 4, 2020·1 cites·23 claims
- 2873US8471005B2Pyrrolotriazines as ALK and JAK2 inhibitorsBRESLIN HENRY J·Filed 2011·Granted Jun 25, 2013·3 cites·10 claims
- 2973US6534510B2Thrombin inhibitorsMERCK & CO INC·Filed 2001·Granted Mar 18, 2003·8 cites·7 claims
- 3073US5646148AHIV protease inhibitors useful for the treatment of AIDSMERCK & CO INC·Filed 1995·Granted Jul 8, 1997·13 cites·6 claims
- 3168US11878966B2Substituted 4-benzyl and 4-benzoyl piperidine derivates89BIO LTD·Filed 2021·Granted Jan 23, 2024·0 cites·1 claims
- 3268US6387911B1Pyrazinone thrombin inhibitorsMERCK & CO INC·Filed 2000·Granted May 14, 2002·4 cites·14 claims
- 3367US6753410B2Investigational compoundsMERCK & CO INC·Filed 2001·Granted Jun 22, 2004·2 cites·5 claims
- 3464US10954251B2Thienopyrimidine inhibitors of atypical protein kinase CCANCER RESEARCH TECH LTD·Filed 2018·Granted Mar 23, 2021·0 cites·19 claims
- 3562US6011038APyrazinone thrombin inhibitorsMERCK & CO INC·Filed 1998·Granted Jan 4, 2000·9 cites·15 claims
- 3661US5668132AHIV Protease inhibitors useful for the treatment of AIDSMERCK & CO INC·Filed 1996·Granted Sep 16, 1997·6 cites·6 claims
- 3761US2009093479A1Anti-cancer agents and uses thereofLOCUS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3860US5932606APyrazinone, pyridinone, piperidine and pyrrolidine thrombin inhibitorsMERCK & CO INC·Filed 1998·Granted Aug 3, 1999·14 cites·8 claims
- 3959US11013726B2Substituted pyridinone-containing trycyclic compounds, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2020·Granted May 25, 2021·0 cites·27 claims
- 4058US5807841AHIV protease inhibitors useful for the treatment of AIDSMERCK & CO INC·Filed 1997·Granted Sep 15, 1998·5 cites·3 claims
- 4158US5527799AHIV protease inhibitors useful for the treatment of AIDSMERCK & CO INC·Filed 1995·Granted Jun 18, 1996·11 cites·3 claims
- 4256US10821103B2Substituted pyridinone-containing trycyclic compounds, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2017·Granted Nov 3, 2020·0 cites·58 claims
- 4356US2024246964A1Substituted 1-aryl-1’-heteroaryl compounds, substituted 1,1’-biheteroaryl compounds, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2022·Application pending·0 cites
- 4456US2024228504A1Substituted tricyclic amides, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 4555US10183950B2Thienopyrimidine inhibitors of atypical protein kinase CCANCER RESEARCH TECH LTD·Filed 2017·Granted Jan 22, 2019·0 cites·10 claims
- 4655US2023312481A1Substituted (phthalazin-1-ylmethyl)ureas, substituted n-(phthalazin-1-ylmethyl)amides, and analogues thereofARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 4755US2023295115A1Substituted isoquinolinylmethyl amides, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 4855US2017027948A1Macrocyclic compounds as alk, fak and jak2 inhibitorsCEPHALON INC·Filed 2016·Application pending·0 cites
- 4954US5717097AHIV protease inhibitors useful for the treatment of AIDSMERCK & CO INC·Filed 1996·Granted Feb 10, 1998·5 cites·6 claims
- 5053US2023143612A1Substituted 1,1'-biphenyl compounds and methods using sameARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
Showing the top 50 of 72 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Bruce D. Dorsey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →